The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study

Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A

(2015) Y. Li et al.   BLOOD

Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment

(2015) Michael Hoffmeister et al.   JNCI-Journal of the National Cancer Institute

Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment

(2015) Michael Hoffmeister et al.   JNCI-Journal of the National Cancer Institute

Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness

(2014) Shuhua Yue et al.   Cell Metabolism

A role for oleoylethanolamide in chronic lymphocytic leukemia

(2014) M Masoodi et al.   LEUKEMIA

Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project

(2014) Julie K. K. Vishram et al.   PLoS One

The Pathogenesis of Chronic Lymphocytic Leukemia

(2013) Suping Zhang et al.   Annual Review of Pathology-Mechanisms of Disease

Chronic lymphocytic leukemia in young (

(2013) S. A. Parikh et al.   HAEMATOLOGICA

Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999–2010

(2013) Hiram Beltrán-Sánchez et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies

(2013) Jan A. Burger et al.   SEMINARS IN CANCER BIOLOGY

Risk categories and refractory CLL in the era of chemoimmunotherapy

(2012) T. Zenz et al.   BLOOD

Metabolic Syndrome and Risk of Cancer: A systematic review and meta-analysis

(2012) K. Esposito et al.   DIABETES CARE

PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia

(2012) D E Spaner et al.   LEUKEMIA

Statin Use and Reduced Cancer-Related Mortality

(2012) Sune F. Nielsen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

(2011) D. Rossi et al.   BLOOD

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

(2011) Víctor Quesada et al.   NATURE GENETICS

The metabolic syndrome

(2010) Robert H Eckel et al.   LANCET

Statin use and need for therapy in chronic lymphocytic leukemia

(2010) Daphne R. Friedman et al.   LEUKEMIA & LYMPHOMA

Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia

(2010) Tait D. Shanafelt et al.   LEUKEMIA & LYMPHOMA

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

For Patients with Colorectal Cancer, the Long-Term Use of Statins Is Associated with Better Clinical Outcomes

(2009) Ali A. Siddiqui et al.   DIGESTIVE DISEASES AND SCIENCES

Pathogenesis and Pathophysiology of the Cardiometabolic Syndrome

(2009) Erik P. Kirk et al.   Journal of Clinical Hypertension

High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort

(2009) M.D. Seftel et al.   LEUKEMIA RESEARCH

Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition

(2008) A. E. Khan et al.   HAEMATOLOGICA